CSL - Loan Capital

Stock Price
140.23
Daily Change
-1.95 -1.37%
Monthly
-3.00%
Yearly
-42.00%
Q2 Forecast
135.92

CSL reported $10.42B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
aTyr Pharma USD 12.51M 12.11M Dec/2025
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Immunic USD 0 0 Jun/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 86.58M Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
TherapeuticsMD USD 0 0 Mar/2022